Search

everythinglearnresearchcommunity

for

Search:↓

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Higher Interleukin 17A levels may indicate more severe alopecia areata.

The nutritional supplement Pilopeptan® WOMAN improved hair growth and thickness in women with hair loss.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Belatacept may be a promising treatment for alopecia areata.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

Baricitinib is the most effective treatment for alopecia areata.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Supplemental testosterone may lower liver cancer risk in hepatitis C patients.

The combined therapy significantly increased hair density and was safe for treating hair loss.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Platelet rich plasma is as effective as triamcinolone for treating alopecia areata.

The silk fibroin hydrogel with FGF-2-liposome can potentially treat hair loss in mice.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.